| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.0053 | 1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.0039 | 1 |